Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

New research shows that most people regain weight after stopping Ozempic and similar weight-loss drugs around the eight-week ...

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

The weight loss drug Wegovy may do more than help people lose weight New trial results show the weight-loss medication Wegovy can also cut heart attack and stroke risks, according to the drug's maker.

The science that helped develop weight loss drug Wegovy is leading to other medications that are expected in 2023. These new drugs can reduce weight up to 20%, though doctors caution that not ...

Wegovy weight loss drug has heart benefits, study found 00:23 (CNN) - Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss ...

In addition, nearly 32% of people taking Zepbound lost at least a quarter of their body weight, compared to about 16% of those taking Wegovy, the study found. Weight loss was about 6% lower in men ...